Showing 20 of 36 recruiting trials for “composite-lymphoma”
PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL
Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
A Study to Investigate the Pharmacokinetics of Tirabrutinib in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Healthy Participants
A Clinical Study on the Efficacy and Safety of Methotrexate (MTX) or Thiotepa (for MTX Intolerance) or Temozolomide (TMZ) Combined With Orelabrutinib and Selinexor in Relapsed/Refractory Primary or Secondary Central Nervous System Lymphoma（SELINA）
A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell Lymphomas
👨⚕️ François LEMONNIER, Pr, Hôpital Henri Mondor - Lymphoid Malignancies Unit📍 20 sites📅 Started Aug 2025View details ↗
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL
A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies
🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Oct 2024View details ↗
Enrolling by InvitationNCT07450040 ↗
Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma
"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCL
PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas
👨⚕️ Shuhua Yi, Doctor, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Aug 2024View details ↗
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
👨⚕️ Daniel R Richardson, MD, MA, MSc, UNC Lineberger Comprehensive Cancer Center📍 1 site📅 Started Jun 2024View details ↗
Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
Effects of Exercise Training in Survivors of Lymphoma
👨⚕️ Tormod S. Nilsen, PhD, Norwegian School of Sport Sciences📍 2 sites📅 Started Mar 2024View details ↗
Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma
RecruitingNCT06362148 ↗
Circulating Tumor DNA in Peripheral T-cell Lymphomas
👨⚕️ Francesco A d'Amore, MD, DMSc, Aarhus University Hospital and Aarhus University📍 1 site📅 Started Mar 2024View details ↗
PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →